Package Leaflet: Information for the User
Doporio 25 mg/100 mgTablets EFG
Carbidopa/Levodopa
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Doporio improves the signs of Parkinson's disease in adults. Parkinson's disease is a chronic disease characterized by:
If left untreated, Parkinson's disease can cause difficulties in leading a normal life. Doporio contains two different active substances called: levodopa and carbidopa.
Do not takeDoporio
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medicine. It is important that before starting to take this medicine, you inform your doctor of any medical problem you have or have had, especially if you have or have had
Tell your doctor if you or your family member/caregiver notice that you are developing symptoms similar to those of addiction, which lead to a desire to take large doses of Carbidopa/Levodopa and other medicines used to treat Parkinson's disease.
Tell your doctor if you or your family member/caregiver notice that you are starting to behave abnormally, if you feel the impulse, initiative or temptation to harm others or yourself. These behaviors are called impulse control disorders and may include addiction to gambling, eating or spending excessively, increased sexual desire or an increase in sexual thoughts or desires. Your doctor may need to review your treatments.
This medicine may affect some laboratory tests that your doctor may perform on blood or urine samples. Remember to tell your doctor if you are taking this medicine and are going to undergo any test.
Tell your doctor if you have been previously treated with levodopa.
Children and adolescents
Carbidopa/Levodopa is not recommended for patients under 18 years of age.
Other medicines andDoporio
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
The effectiveness of the treatment may change if Carbidopa/Levodopa is used concomitantly with other medicines. Tell your doctor if you are taking any of the following medicines:
Taking Doporio with food
Try to avoid taking Carbidopa/Levodopa with a meal that contains protein (such as meat, eggs, milk, cheese) as the function of Carbidopa/Levodopa may decrease.
Pregnancy andbreast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Carbidopa/Levodopa is not recommended during pregnancy or in women of childbearing age who do not use contraceptive methods unless the benefits to the mother outweigh the possible risk to the fetus.
Do not take Carbidopa/Levodopa if you are breast-feeding.
Driving and using machines
The effects of this medicine may vary individually. Adverse effects have been observed that in some patients may affect the ability to drive or operate machinery in relation to the use of carbidopa/levodopa (see "Possible side effects").
Carbidopa/Levodopa may cause excessive drowsiness and sudden episodes of sleep. Therefore, you should avoid driving vehicles or performing activities (e.g. using machines) in which reduced reaction ability may pose a risk of potentially fatal injuries, until such repeated episodes of sleep and/or drowsiness have disappeared.
Doporio contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; i.e. it is essentially "sodium-free".
Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended daily dose may be variable and is individually determined by the doctor through an individual dose adjustment according to the severity of your disease and your response to treatment. During the dose adjustment period, the patient should pay special attention to symptoms such as involuntary movements and inform their doctor immediately if this occurs. Your doctor will adjust your dose as necessary.
Your doctor may prescribe you more than one dose of carbidopa/levodopa. If you have been prescribed different doses of carbidopa/levodopa, make sure you are taking the correct tablet at the right time.
For doses that are not possible/practical with this medicine, other medicines are available.
How to take this medicine
The tablet can be divided into equal doses.
If you takemore Doporio than you should
If you have taken more carbidopa/levodopa than you should, or if a child has taken a medicine by accident, consult your doctor or hospital for an opinion on the risk and instructions on the measures to be taken.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to takeDoporio
Take Carbidopa/Levodopa as prescribed. However, if you forget to take a tablet, take it as soon as you remember. If it is almost time for the next dose, do not take the missed dose and wait until the next dose. Do not take a double dose to make up for the missed doses.
If you stop taking Doporio
Do not stop taking Carbidopa/Levodopa or reduce the dose without first consulting your doctor. Stopping the medicine may cause some symptoms such as muscle stiffness, fever or mood changes.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Contact your doctor immediately if you experience any of the following symptoms:
Other side effects that may occur:
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Frequency not known (cannot be estimated from the available data):
Impulse control disorders may also occur:
Inability to resist the impulse to perform an action that could be harmful, including:
Tell your doctor if you experience any of these behaviors as they will seek a way to control or reduce the symptoms.
Other possible side effects:
Carbidopa/Levodopa may affect some blood test results, such as elevated liver function test values and blood sugar values. Bacteria and blood have also been detected in the urine. Carbidopa/Levodopa may cause a false positive reaction for ketone bodies in the urine.
If you experience unusual symptoms, consult your doctor or seek immediate treatment.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage temperature. Store in the original packaging to protect from light.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date is the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Doporio Composition
Product Appearance and Packaging Contents
Doporio 25 mg/100 mg are round white or almost white tablets, 10 mm in diameter, with a score line and marked with "LC 100" on one side.
Doporio is available in HDPE bottles of 100 tablets.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Orion Corporation
Orionintie 1
FI-02200 Espoo
Finland
Manufacturer:
Orion Corporation Orion Pharma
Joensuunkatu 7
FI-24100 Salo
Finland
For further information about this medicinal product, please contact the local representative of the marketing authorization holder:
Orion Pharma, S.L. Avda. Alberto Alcocer 46 B 10ºE 28016 Madrid Spain |
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Czech Republic | Pipoda |
Denmark, Finland, Ireland, Norway, Sweden | Carbidopa/Levodopa Orion |
Lithuania, Estonia, Latvia | Levodopa/Carbidopa Orion |
Hungary, France | Parlekarv |
Poland, Romania, Bulgaria | Parkador |
Slovakia | Carlevo |
Belgium, Croatia, Netherlands, Spain, Slovenia | Doporio |
Italy, Portugal | Oridopa |
Date of Last Revision of this Leaflet:December 2024
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of DOPORIO 25mg/100mg TABLETS in October, 2025 is around 11.26 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.